COLDA
Meeting category
Date(s)
29 Sep 2022 - 1 Oct 2022
Program Language
English, French
Location
Cape Town, South Africa
Organizer

Conference on Liver Disease in Africa (COLDA) 2022

Related Enduring Materials

Enduring Materials
Day 1: Thursday, 29 September
Opening of the Conference - Call for Action -
Call for Action: We Need to Address the Challenges - Now
Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
University of Cape Town, South Africa
Call for Action: We Need High Quality Data To Plan Services
Olufunmilayo Lesi, MD, MBA, FWACP, FMCP
World Health Organization, Switzerland
Call for Action: We Need Solutions
Agnes Binagwaho, MD, M(Ped), PHD
University of Global Health Equity, Rwanda
Call for Action: We Need Testing & Treatment - Now
Session 1: Hepatitis Elimination Part I - Screening/Testing/Monitoring -
From Pandemic Response to Pandemic Recovery - Opportunities for Viral Hepatitis Elimination
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Blood Safety & Surveillance
Yuyun S. Maryuningsih, MD, PhD
World Health Organization, Switzerland
Session 2: Hepatitis Elimination Part II -
Vertical Transmission - Maternal Care Resulting in Family Care
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
Day 2: Friday, 30 September
Session 3: Integration Hepatitis Care Into Other Health Care Services -
Integrated Decentralized Guidelines for Care - WHO Guidelines
Philippa Easterbrook, MD, FRCP, MPH, DTM&H
World Health Organization, Switzerland
Can Integration Reduce Stigma? - Lessons Learned From HIV
Danjuma K. Adda, MPH, FIMS, Dip-IMS
World Hepatitis Alliance (WHA), Nigeria
Integrating Hepatitis B Into HIV Programs in Sub-Saharan Africa: Pilot Clinic Experience in Zambia
#1 - Wamundila Kawana
Department of Medicine - University Teaching Hospital / School of Medicine - University of Zambia, Zambia
Session 4: Clinical Management of Hepatitis - Abstract-Driven Presentations -
5-Year Results of a Treatment Program for Chronic Hepatitis B in Ethiopia
#2 - Hailemichael Desalegn
St. Paul's Hospital Millennium Medical College, Ethiopia
Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic
#3 - Gibril Ndow
MRCG Unit The Gambia at LSHTM, Gambia
Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother-To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso
#4 - Serge Ouoba
Hiroshima University, Japan / Institut de Recherche en Science de la Santé (IRSS), Burkina Faso
Hepatitis Delta Virus Co/Super-Infection Surveillance among Clinicians: An Often-Neglected Practice in Nigeria
#5 - Ijeoma Ifeorah
University of Nigeria, Nigeria
Séroprévalence du virus de l’hépatite D (VHD) chez des patients porteurs chroniques de l’antigène HBs du virus de l’hépatite B (VHB) à Abidjan de janvier 2017 à Aout 2021 (COTE-D’IVOIRE)
#6 - Jean-Louis Philippe N'din
Centre Intégré de Recherches Biocliniques d'Abidjan (CIRBA), Côte d'Ivoire
Session 6: Clinical Management of Liver Disease - Abstract-Driven Presentations -
Hepatitis C Laboratory Data Analysis on Patients Seeking Medical Attention in the Public Health Sector, South Africa, 2017-2021
#7 - Morubula J. Manamela
NICD, South Africa
Performance-Based Approach to Accelerate Hepatitis C Elimination in Rwanda
#8 - Janvier Serumondo
Rwanda Biomedical Centre, Rwanda
Prevalence and Mortality Trends of Hepatitis B and Hepatitis C Infection in Sub-Saharan Africa: A Systematic Analysis for the Global Burden of Disease Study 2020
#9 - Hannah Han
Institute For Health Metrics And Evaluation, United States
Trends of Hepatitis-Associated Cirrhosis and Liver Cancer in Sub-Saharan Africa: A Systematic Analysis of the Global Burden of Diseases and Injuries Study 2020 (Gbd 2020)
#10 - Hannah Han
Institute For Health Metrics And Evaluation, United States
An Assessment of Metabolic Syndrome and Cardiovascular Risk Scores Among Patients With Non-alcoholic Fatty Liver Disease (NAFLD) at the Cape Coast Teaching Hospital, Ghana
#11 - Ansumana Bockarie
University Of Cape Coast, Ghana
Session 7: Clinical Management of Viral Hepatitis -
State of the Art Lecture: HBV Cure
Geoffrey Dusheiko, MBBS, FCP(SA), FRCS
King's College Hospital / University College London Medical School, United Kingdom
Session 8: Project ECHO - Challenging Clinical Cases on Viral Hepatitis -
HBV Case - When is it NOT Acute Hepatitis B?
Sandy Mpho Mosenye, Bsc, MBChB, MMed, FCP(SA)
Hepatology Fellow, University of Cape Town, South Africa
HCV Case - Understanding Patterns of Hepatitis C Transmission in a Rural Community
Elizabeth Gatley, MBChB, FCP (SA)
Hepatology Fellow, University of Cape Town, South Africa
Panel Members
Stephen Korsman, MBChB, FCPath(SA)Viro, MMed
University of Cape Town, South Africa
Day 3: Saturday, 1 October
Session 9: AASLD - African Guidelines in HCC -
Early-Stage Disease
Ashraf Omar, MD, MSc
Cairo University, Egypt
Late-Stage Disease
Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center / Weill Medical School at Cornell University, United States
Session 10: The Challenges of Hepatobiliary Surgeries in Sub-Saharan Africa -
Liver Surgery
Eduard Jonas, MB, ChB, MMed, FCS, PhD
University of Cape Town / Groote Schuur Hospital, South Africa
Liver Transplantation Models
Amr Abdelaal, MD, FACS
Ain Shams University, Egypt
Elie Keli, MD
Treichville University Hospital, Cote d’Ivoire
Long-Term Follow-up in Liver Transplant Recipients: First Local Experience.
#12 - Nabil Debzi
University Hospital Mustapha Bacha, Algeria
Roundtable Discussion
Eduard Jonas, MB, ChB, MMed, FCS, PhD
University of Cape Town / Groote Schuur Hospital, South Africa
Amr Abdelaal, MD, FACS
Ain Shams University, Egypt
Elie Keli, MD
Treichville University Hospital, Cote d’Ivoire
Abdelmounem Abdo, MD
Ibn Sina Hospital, Sudan
Nabil Debzi, MD
Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria
Session 11: Management of End Stage Liver Disease - Real Life Challenges -
Cirrhosis Management in Resource Constraint Environments
Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed
University of Cape Town, South Africa
General
Invitation to Join COLDA 2022
Organizing Committee member, Geoffrey Dusheiko, invites you to join COLDA 2022 from 29 September - 1 October in Cape Town, South Africa!
Welcome

Co-organized by Academic Medical Education and the SHARE Global Health Foundation in close collaboration with regional societies, COLDA 2022 aims at empowering healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa. This being the 5th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with support from an international community of experts, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context.

We aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and debates with ample time for discussion.

We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge, and experience a wide spectrum of topics related to liver disease.

Program Chairs 2022
Local Chair 2022
The SHARE Global Health Foundation

The SHARE Global Health Foundation is a non-profit organization dedicated to advancing global health by sharing and implementing expertise and evidence-based knowledge internationally.
SHARE focuses on identifying innovative educational programs and implementation strategies to empower physicians, community representatives, and stakeholders in low- and middle-income countries with the knowledge needed to improve services and policies in both governmental and private institutions. 

Visit the SHARE website for more information. 

share foundation

General Information 

Who Should Attend?
• Physicians
• Hepatologists
• Gastroenterologists
• Researchers
• Other healthcare professionals (nurses, clinical officers, community health workers, among others)
Meeting Objectives
COLDA aims to:

- Gather experts from the African region involved in the research, diagnosis, and treatment of liver diseases in an interactive conference setting;

- Discuss the diagnostic, therapeutic, and preventative efforts of liver disease tailored to regional and local needs, translating best practices into daily practice guidelines and policies;

- Contribute towards hepatitis elimination efforts;

- Leverage on the findings from international studies through the delivery of updates from major meetings that can be applied at the local and regional level to combat liver diseases;

- Facilitate a robust dialogue among participants through interactive networking and a networking reception; and

- Foster new and lasting interdisciplinary partnerships and collaborations among various researchers to improve knowledge sharing with aim of combating liver diseases in Africa.
Learning Objectives
After participating in COLDA, participants will be able to:

- Discuss the epidemiology and treatment of liver disease at an individual and population level;

- Ensure the knowledge and availability of HBV and HCV therapy and their correct usage;

- Discuss evolving modalities of monitoring liver disease and their availability in the African setting; and

- Update on new developments in the investigation of liver disease and their use in an African setting.

Practical Information 

Venue
Double Tree by Hilton - Cape Town Upper Eastside
31 Brickfield Road,
Cape Town, 7935, South Africa

Distance from Cape Town International Airport: 9.32 km
Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they have attended the conference and completed the post-meeting survey.
Language
The official conference language will be English. Translation to French will be available.
Enduring Materials
Enduring materials will be available here shortly after the conclusion of the conference.
Disclaimer
The conference is co-organized by Academic Medical Education and the SHARE Global Health Foundation and the conference secretariat is Virology Education BV. This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference organizer and conference secretariat cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. The conference organizer and conference secretariat disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the conference organizer and conference secretariat do not accept responsibility for any applicable insurances. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the conference organizer and conference secretariat may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided that the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

Registration for COLDA 2022 is now closed!

Fees and Conditions

Academia

RLS/ECI

Industry

Early Fee (payment before/on 28 March 2022)

€300.00

€150.00

€1645.00

Regular Fee (payment before/on 28 June 2022)

€400.00

€175.00

€1845.00

Late Fee (payment before/on 28 September 2022)

€450.00

€200.00

€1945.00

Same Day Fee (payment from 29 September 2022)

€500.00

€225.00

€1995.00

Discounts

Early-Career Investigators (ECI) / Academia from Resource-Limited Settings (RLS)* WITH an accepted abstract

Fee Waived

NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates

50% Off Current Academia Fee

Members of Endorsers

25% Off Current Academia Fee

Sponsors

Contact Secretariat

If you are eligible for a discount or have have financial concerns, please contact the conference secretariat via magda.sevlidou@amededu.com.

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important
  • We strongly advise that you register early to ensure that your registration is secured.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
- Access to all scientific sessions, including virtual poster area

- Conference pack, including abstract book and program

IMPORTANT:

- No day rate is available.

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Academia from Resource-Limited Settings (RLS) / Early-Career Investigators
The registration fee will be waived for academia from low-income and lower-middle-income countries and early-career investigators with an accepted abstract and a 50% discount on the registration fee for those without an accepted abstract.

IMPORTANT: The registration fee is waived for the presenting author only.

To be eligible as an early-career investigator, one either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the conference. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Sponsored Attendance
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Payment
By credit card only: online or by written authorization.
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 29 August 2022: 50% refund (minus an administration fee of €40)

- Cancellation after 29 August 2022: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 15 September 2022. A statement (email/letter) of cancellation must be sent magda.sevlidou@amededu.com.
Liability and Insurance
By registering for the conference, participants agree that the conference organizer and conference secretariat do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference organizer and conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previously written assignments in recognized outlets on liver disease. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this conference

A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your conference report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the conference. Media representatives are kindly requested to register by sending the above-mentioned information to info@share-foundation.com

Important: Media is restricted to the written press. Recording on film or photo is not allowed. The conference organizer and conference secretariat will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Disclaimer
The conference is co-organized by Academic Medical Education and the SHARE Global Health Foundation. This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference organizers and conference secretariat cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. The conference organizers and conference secretariat disclaim all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Early-Career Investigator Form

Please download and complete the below form. 

After completing the form, please return it to the conference secretariat at magda.sevlidou@amededu.com or upload it as part of your registration scholarship application.

Abstracts

The Abstract Submission Portal is closed. The deadline was 1 July 2022 at 23:59 SAST.

Abstracts
  • Abstract submission is closed. The deadline was 1 July 2022 at 23:59 SAST.
     
  • COLDA 2022 accepts new original data as well as encored abstracts. All abstracts are focused on the African region and contain up-to-date information at the time of the conference. 
  • The registration fee is waived for academia from low-income and lower-middle-income countries and young investigators with an accepted abstract. A 50% discount is offered to academia from low-income and lower-middle-income countries and young investigators without an accepted abstract. 

  • Abstracts can be submitted in either English or French.

Image
COLDA - online participation - Stock photo
Terms and Conditions

By submitting an abstract to a meeting where Virology Education BV (VE) is the conference secretariat, the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here

Topics for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate topic is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

Abstracts can be submitted under the following categories:

- Civil Society Experience: Impact of COVID-19 on Liver Services
- COVID-19 Related Liver Disease
- Liver Disease Diagnostics Tools
- Drug Induced Liver Disease Including Alcohol
- End Stage Liver Disease (Incl. Cirrhosis, HCC)
- HBV Prevention, Testing and Treatment
- HCV Prevention, Testing and Cure
- Hepatitis Co-Infections
- Hepatitis Vaccinations
- Hepatobiliary Surgery
- Implementation Elimination Strategies
- Other Causes of Hepatitis (Incl. Infectious, ETLG, Fatty Liver)
- Pediatric Liver Disease
General Guidelines
Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the conference and present their abstract as scheduled.
Abstract Submission
Authors can submit their abstracts electronically until 1 July 2022. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Abstract Publication
Accepted abstracts will be published in the Abstract Book: the Journal Reviews in Antiviral Therapy & Infectious Diseases. This will be distributed during the conference and will be available as enduring material after the conference has concluded. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.

VE and AME is the sole copyright holder of the conference abstract book as a whole (also referred to as the Reviews in Antiviral Therapy & Infectious Diseases). The abstract authors will retain any and all copyright over their individual abstract. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Committees
Organizing Committee
Ward, John 2023
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

To augment the organizing committee, the following are scientific committee members

  • Mary Afihene, MBChB, FWACP – Kwame Nkrumah University, Ghana 

  • Kosh Agarwal, MD - King’s College Hospital, United Kingdom

  • Nabil Debzi, MD - Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria

  • Alice Guingané, MD, MPH - Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France

  • Kenneth Kabagambe - National Organization for People Living with Hepatitis B, Uganda

  • Emmanuel Musabeyezu, MD, FCP – King Faisal Hospital, Rwanda

  • Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana

  • Gibril Ndow, MD – Imperial College London / London School of Hygiene & Tropical Medicine, The Gambia

  • John Rwegasha, MBChB, M.MED, FRCP, MSc - Muhimbili National Hospital, Tanzania

  • Edford Sinkala, MD, PhD - University Teaching Hospital / University of Zambia, Zambia

  • Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland

  • Elijah Songok, MD, PhD - Kenya Medical Research Institute, Kenya

  • Christian Tzeuton, MD – Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Principle Supporter Level
Supporter Level
Contributor Level
Friend Level
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in liver diseases in Africa.
 
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Karin Siebelt at Karin.Siebelt@share-foundation.com or call +31 30 230 7149
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, program book, the streaming platform, and our website
  • Digital advertising opportunities 
  • Social media shout-outs
  • Logo on the digital conference bag 
  • Exhibition

 
*Subject to the support level

Endorser

A 25% discount on the meeting registration fee is offered to the members/employees of our endorsers. Please reach out to your organization for your discount code.

If you would like your organization to endorse COLDA 2022, please contact Rikke Puggaard-Rode at rikke.rode@share-foundation.com

Media
Invitation to Join COLDA 2022

Organizing Committee member, Geoffrey Dusheiko, invites you to join COLDA 2022 from 29 September - 1 October in Cape Town, South Africa!

Previous Editions
Top-Rated Materials from Previous Editions

The Story of Hepatitis C: Translating Science to Clinical Reality - Harvey J. Alter, MD, MACP

COLDA 2021

Scholarships

Scholarship Application is Open

Scholarship Application Deadline: Sunday, 18 September at 23:59 CEST/SAST/CAT.
Scholarships

SHARE Global Health Foundation, with support from the industry, is offering scholarships to attend COLDA 2022. The scholarship covers registration for in-person attendance.

The scholarship application deadline is Sunday, 18 September at 23:59 CEST/SAST/CAT.

What is Expected from the Scholarship Recipients?

All scholarship awardees are required to attend the full conference. Awardees must sign in at the beginning of each meeting day and sign off at the end of each day as requested by the Conference Organizer. At the close of the conference, awardees must have completed the daily and overall conference evaluations.

Recipient will provide post-conference feedback and a summary about his/her conference experience within one month after the end of the conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, scholarship procedure, and how they will implement the knowledge acquired at the conference in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the conference.

What does the Scholarship Cover?
There is 1 type of scholarship:
- Registration Only
Eligibility
Applicants must:
- Be Academia from Resource-Limited Settings
- Be proficient in English to interact with faculty and fellow attendees
- Be actively involved in the field of liver diseases in Africa
- Be able to show benefits to their patients / research / community from attending the meeting
- Be willing and able to share information learned at the meetings with a larger community

The Conference organizer will automatically decline all scholarship applications that do not conform to the eligibility terms.
Application Procedure
The scholarship applications must be submitted online through our Scholarship Application Portal by Sunday, 18 September 2022. The applicant will be asked to submit a motivational letter (max. 200 words) describing how their patients/research/community will benefit from the knowledge gained at this meeting, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

- All applications will be acknowledged upon receipt.
- All applications will be reviewed by an independent Scholarship Review Committee.
- Successful applicants will be sent a scholarship agreement.
- After receipt of the signed scholarship agreement, successful applicants will receive instructions for logistical arrangements.
Selection Criteria
- Professional background;
- Country of residence;
- Recommendation by your supervisor;
- Demonstrable benefits to patients / research / community by the knowledge to be gained at this meeting;
- Strategy of knowledge dissemination;
- Early-Career Investigator; and
- Abstract presenters.
Scholarship Terms and Conditions
- The applicant will attend the entire conference program.
- The applicant will provide the completed post-meeting feedback and summary to Conference Organizer.
- The applicant is able and willing to fund all other costs beyond the grant that are involved in attending the Conference, e.g. all other hotel, travel, subsistence, insurance, and other expenses NOT covered by the Scholarship.
- The applicant will not hold the Conference Organization liable for any losses, costs, expenses, causes of action, claims, and suits for property damage, theft of property, or personal injury (including death) arising in connection with the Scholarship and participation in the Conference.
- The applicant agrees to be responsible for taking out her/his own insurance policies (travel, liability, and/or other necessary insurances in relation to his/her participation in the Conference).
- The Scholarship is non-transferable.
- Incomplete scholarship applications will not be considered.
- Retrospective scholarship applications will not be considered.
- Conference Organizer cannot be held responsible for any incorrect information that is submitted through the Scholarship application portal.
- Scholarship applications will be considered until the exhaustion of funds.
- The Scholarship applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
- Conference Organizer reserves the right to make the final decision regarding all Scholarship applications, which cannot be disputed.
Language
Ratings previous edition
Content is relevant to my practice
4.7
(185)
Content was free from commercial bias
4.5
Overall event experience
4.9